The difference with any competitor compared to CYDY is the amount of excluded patients usually the sickest most critical are not even included in those trials, and safety profile of CYDY can not be touched. Also CYDY is many weeks if not months ahead of any competitors even hgen and rlft.,as far as investing goes they are not in the same bracket or category as CYDY because they don’t have an ocean full of indications they may have 1-3 that also small market not 30 billion HIV, 60+ billion Cancer, than you know the 20+ other ones along with cd-12 Covid and Long Haulers. I don’t like even hearing people say CYDY has covid competitor competitors to be honest, it’s like comparing Walmart the one stop shop to your local 7-11.